Most Read
An interview with Paolo Prandoni
Paolo Prandoni Department of Cardiac, Thoracic and Vascular Sciences – Università di...
Management of CAT in the colorectal cancer patient
Our speakers, Alfonso De Stefano and Andres Muñoz, shared some recent updates on cancer-associated thrombosis...
Real-world CAT patient profile from the RIETE registry
During the ICTHIC webinar, “What is the profile of the real-world CAT patient?”, Dr. Laurent Bertoletti gave a...
Coagulopathy and thrombosis in COVID-19 patients: parameters to be checked to assess disease severity
As the clinical evidence keeps on accumulating, we can clearly state that coronavirus disease 2019 (COVID-19) very...
CAT management in older cancer patients
During the ICTHIC webinar, “Challenges in the management of fragile CAT patients (older patient population &...
Risk prediction for cancer‐associated thrombosis: A talk with Prof. Pabinger
Professor Pabinger is a hematologist at the University of Vienna, where she studies cancer and thrombosis. During the...
Drug-drug interaction prevalence in CAT patients
Drug-drug interactions (DDIs) between anticoagulants (AC) and anticancer therapies present a significant concern in the...
An interview with Dr. Alok Khorana
We met with Dr. Alok Khorana in Berlin during the ISTH 2017 Congress. He could not hide his enthusiasm about the...
Inpatient thromboprophylaxis in cancer patients: what is the evidence? A talk report from the 10th ICTHIC
During the 10th ICTHIC, Prof. Jeffrey Zwicker (Harvard Medical School, MA, USA) gave an overview of the evidence of the...